Overview
Crexont is approved by the U.S. Food and Drug Administration (FDA) for the treatment of Parkinson’s disease, post-encephalitic parkinsonism (Parkinson-like symptoms following brain inflammation), and parkinsonism…
Overview
Dhivy is approved by the U.S. Food and Drug Administration (FDA) for the treatment of Parkinson’s disease, as well as post-encephalitic parkinsonism and symptomatic parkinsonism caused by carbon monoxide or…